Brooks Votes Against Jeopardizing Biomedical American Innovation
WASHINGTON, DC – Today Congresswoman Susan W. Brooks (R-IN05) provided the following statement after voting against H.R.3:
“Every cure we do not discover is a life we will not save. Congress has found a bipartisan solution to lower drug costs while ensuring the United States will continue to be on the cutting edge of biomedical research, innovation and breakthrough medicines to develop cures,” said Rep Brooks. “I am disappointed the majority did not advance this bipartisan legislation that has a real chance of being signed into law today to provide real relief for Americans. Instead Democrats moved H.R. 3, which, according to the Congressional Budget Office would result in 15 fewer cures being developed. The Council of Economic Advisers says that number is likely closer to 100 fewer cures. H.R. 19, The Lower Costs, More Cures Act is the solution to lower drugs costs and protects our seniors by capping out of pocket costs. We know this bipartisan language would have worked through the Senate and been signed into law by the president.”
To watch Brooks’ remarks on the House Floor, click here.